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The 30-minute immobilization stress was shown to
raise significantly the non-enzymatic fibrin-
olytic activity of blood in rates. Combined with
ACTH the effect is still greater. I. v. administration
of 0.2 ml 0.011 solution if urotaiminsulnhate
prevented the non-enzymatic f rbrinolysis induced by
r the stress. Administration of ACTH after
protaminsulphate again raisedthe fibrinolysis.
This suggests that ACTH stimulates-the release of
'	 heparin.
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By B. A. Mx1ryashw,* F. B. Shapiro* E. G. Icmmmkaya* and L. A. Lyapinai*
in the adaptive humoral reactions to stress effects,one of the central.
	
/735**
places is undoubtedly occupied by processes directed both towards natural pre-
vention of possible blood loss, and towards preservation of the fluid state of
circulating blood, guarding the organism from possible	 boc	 i s. It is
known that these physiological processes that prevent "mo- bogenesis are associ-
ated primarily with the function of a very labile and reactive antLooagulative
system. The studies conducted in this field have demonstrated that during exci-
tation of the anticoagulati ve system in the blood complex ca qxx dds of heparin
develop with blood proteins and certain hornrones,that possess anticoagulative
properties and the capacity to lyse unstable clusters of fibrin, i.e., to imple-
ment nonenzymatic fibrinolysis [4-6).
An inVortant role in the activation of the function of the antieoagulative
system during stress is played by the altered hormonal status of the organism that
is due to intensified secretion of adrenaline, ACM and glueoeorticoids. Adrena-
*Chair of Animal Physiology,tioscow State Universitv (B. A. Kudryashov, Head).
**Numbers in margin indicate pagination in original foreign text.
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Una, an the one hand, and ACTH-glu0000rtiaoids, on the other hand, have a stinu-
lating effect on the no wuynnntic fibrinolysis, intensifying the process of forma-
tion of cmplex heparin cagourds. Any experimental effect during which the dis-
charge of ACTH and g	 icoids carmot be implanented	 under stress
conditions or the action of adrenaline be realized (blockade of ACTH secretion,
adrenalectany, blockade of cx-,adramr+eoeption) • naturally results in inhibition of / 736
the nonenzymatic fibrinolysis, or in other worcds,in a decrease in the functional acti-
vity of the anticoagulative system [13, 141. Here one should bear in mind, that
the stimulating effect of ACTH-glucocort3ooicls and adrenaline on the process of
complex heparin compound formation has an I1xim skdeht nature and is not summed up.
Thus, in the organism there exist two parallel paths for guarantee of inten-
sified nonenzymatic fibrinolysis during stress effects on the organism.
The stimulating effect of adrenaline on the process of formation of heparin
complexes is mediated through developing thrad inogenesis [3, 15, 241, that
naturally stimulates the anticoagulative system and thereby even activation of
the nonenzymatic fibrinolysis. Here the thrcmbogenic effect of adrenaline is imple-
mented through the autonomic nervous system and odic reception [8, 91.
It is still difficult to say anything definite about the mechanism of action
of WM-glucocorticoids. The possibility is not excluded that here stimulation
of blood coagulation and subsequent activation of the function of the anticoagu-
lative system also occur. But it is quite possible that some other mechanisms
lie at the basis of the stimulating effect of the AKIN-glu0000rtieoids. In this
respect the question is important of whether ACTH-glucocortieoids induce intensi-
fication of the nonenzymatic fibrinolysis, by stimulating the discharge of heparin,
since it is known that during activation of the anticoagul.ative system intensifi-
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cation of formation of oompleac heparin oampounds is preceded by discharge of
heparin and activators of plasminogen into the blood. In order to anwaw this
question, we decided tc clarify whether discharge of heparin occurs under the
influence of ACTH-gluc000rticoids during a stress effect, and whether the nai--
enzymatic fibrinolysis is	 dingly
	
if heparin is prelim) narily
bonded by the administration of pr+otamine sulfate in animals in vivo.
Wbrk was conducted on mongrel role rats weighing 170-200 g. She stress state
was induced by 30-minute immobilization (tying to a table). Blood was taken from
the v. jugularis with sodium citrate in a ratio of 9:1. She total fibrinolytic
activity of the blood was determined according to the method of Astrup and Mullertz
[211,  the nanenzymatic fibrinolysis impletrented by the complex heparin oanposu ds-
according to the method of B. A. M dxyashov and L. A. Lyapina with epsilon-w&no-
caproic acid (EWA) that inhibits the effect of plasmin [7] . Protamtiine sulfate
(firm SPM) in a physiological solution (0.01$) in different doses was adminis-
tered intravenously; five units of ACTH (S. M. Kirov Meat -,,mbine) and 1 and 2
mg/100 g of hydr000rtisone (firm Gedeon Rikhter) in a physiological solution intra-
abdaninally within 15 minutes after administration of protwune sulfate, when a
oorplmc protamine sulfate-heparin had already been formed. She volume of the admin-
istered substances was 1 ml; in all cases an equal volume of physiological solu-
tion was administered intravenously or intra-abdominally for the control. In a
determination of the fibrinolytic activity on the unstaoilized platelets of fibrin
by factor 13, prepared according to the method of B. A. Kudryashov, L. A. Lyapina,
and I. P. Baskova [12], 0.05 ml of plarana with a physiological solution or EWA
were applied, and incubated for 2 hours at 37°. The magnitude of the fibrinolytic
3
activity was judged according to the size of the lysis mono an the fibrin plate-
lets per 1 m2.
PERM 5 OF SMW AND THEIR DM3 W IM
To answer the question of whether release of heparin occurs under the influ-
enoe of ACTH-gluoovartico3ds it was decided, as already indicated above to bond
heparin with the help of protamine sulfate. that foams with it,,as is known, a
stable complex inactive in a lytic sense, and thereby under stress conditions
to blocl:	 the possible foaation of other complex heparin cagxux s that possess
fibrinolytic activity ,i.e.,to block ncnenzymatic fibrinolgsis. Omplete blodcaae
of the lytic activity of the w plea heparin compounds with the help of protamine
sulfate in vitro is a known fact [10]. rn that case, if after bonding of heparin
by protamine sulfate in vivo nonenzymatic fibrinolysis again would begin to be 	 /737
implemented under the influence of ACTH-gluoovor
	 , there would be all
grounds to consider that they induced additional release of heparin.
First of all it was necessary to detenaine the threshold dose of protamine
sulfate, for with the administration of a surplus of protamine sulfate, evidently,
the newly released heparin would also be bonded. Table 1 presents results of the
detezminatiom of the nonenzymatic fibrinolytic activity in rats who received an
intravenous dose of a varying quantity of protamine sulfate and were er,)Oseu to
immobilization stress.
As one can see from these data, the threshold dose of protamine sulfate for
bonding heparin in vivo under our experimental conditions is 0.2 ml of a 0.01%
solution. With the administration of this quantity of protamine sulfate the non-
enzymatic fibrinolytic activity during stress is practically mat manifest (group 5);
4
its absolute amount in only 2.0 =2, while the percentage in the total fibrino,-
lytic: activity of blood is 4.3%. Mwwver, in the ocritrol animals who reosived a
physiological solution these wamts respectively wrialled. 37.1 =2 and 46.7%
(group 1). The aftmistration of 0.1 ml of protamins, sulfate was insufficient for
bonding heparin,, and nonenzymatic fibri.nolysis during straw remains the same as
in the control animals (group 6). The administration of 0.3-0.5 ml of protamine
sulfate ocmpletely blocki nonenzymeltic fibrinolysis,, but evidently if tt 1 , l doses
are 
used 
we will a fortiori irtroduoe a surplus of protamue sulfate, on vtxm
background the now release of heparin will be difficult to catch.
TABLE 1. NONENZYMATIC FIBRINOLYTIC ACTIVITY DURnG ►t4OBIUZhMCN STFM AFTER
ADKnaSTRkT1M CF PPOMMINE SUIPATE
No. of of Zone of
ArUL.Tals 
ILY= 4=
2 )
'S Zia +EACK_ B x 100
(A) (B)
1 77.5+4.3 37.1+1.1 ► 46.7	 2.0
10 38.1± 5.3 W
6 ,5.;1+3.2 0
6 34.5+4.2
 0
9 43.9:F 2.6 2.0+1.0 4.34 41-5
7 75.313.1 39.3	 4.4 51.3±2.3 
Group of Animals
Physiological solution
0.5 ml of protamine sulfate
0.4 ml
0.3 ml
0.2 ml
0.1 Ml
Table 2 presents data an the magnitude of nonenzymtic fibrinolytic acti-
vity in animals who received ACTH after heparin was bmxW in them by the adminis-
tration of a different quantity of protamine sulfate.
TABLE 2. NONENZMTIC FIBRnULYTIC ACTIVITY DURM IM' OBILURTIM STPESS AFTER
AMMSMM= . CE UW=_AW= -AND ACTIt
I Zone of	 zone of
No. of iLysis (Ml 2); LYSiS + 2 B x 100Group of Aninwls	 AWMIS	 Ugh (M)(A)	 A
AM	 X)	 136.7+4.2 90-3+2 .3 	 60.0+11.4
0.4 ml protanine sulfate 4ACTH	 9	 46.4 t 4,34'..1 i 7 . L1	 13. -)4-5.0	 31,3 7.70.3 ml	 212	 77.0 -3.7	 46.0±4.1	 .'18,0 2A
0.2 ml
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As we see, the administration of AM after a thr est old dose of pcotamins
sulfate (0.2 ml) resulted in the fact that foQamstion of catpieoc heparin oaap=ds
began again, and noes , quatic fibrinolysis again reaches the lannsl dear 1 A -_ stic
for combined immobilization stress and AM (groups 1 and 4) , :when the percentage /738
of non e r1matic fibrinclytic activity in the total fihrinolytic activity of the
blood is -60%. AC1ii adaainistraticn on a background of large doses of protamine
sulfate (0.3-0.4 ml) yielded, as should be expected, an effect that is inversely
proportional to the surplus protamine sulfate introduced into the organism (groups
2 and 3) , that again band the released heparin. 7lws, there are all the grounds to
believe that ACM stimulates heparin release and at the setae time creates the possi-
bility for a significant intensification in nawwymatic fibrinolysis.
Naturally the question arises of whether this effect of ACITH is mediated
through gluoocorticoids; if it is mediated through activation of the adrenal cortex,
then the release of heparin evidently can also be induced by the a3nitnisttaticn
of a glu0000rticoid hot=*. Zb explain this,after bonding heparin with protsmine
sulfate we administered to the rats under immobilization stress not ACM, but that quan-
tity of hydr000 tisone (1 mg/100 g) that, as we previously established (11], norma-
lizes the formation of omplex heparin compounds in adrenalectamized rats in a
stress state. The findings are presented in Table 3 and Figure 1. It was found
that administration of 1 vg/100 g of hydr000rtisone in a background of protanine
sulfate did not result in a new release of heparin, and nonenzymatic fibrinolytic
activity practically remained on the same level as with administration of only
protamine sulfate (groups 1 and 2) . The pattern was not altered by the adminis-
tration of a doable quantity of hydrooartisone (2 mg1100 g); no release of heparin /739
followed and r=enzymatic fibrinolyt is activity was not increased (group 3) . The
6
TNUE 3. NM*NZ14k= P1
	 ACPIVM DURIIG IPNOB=LXTMN 91109 A?=
AEmnavamm Qs' Pioinm Stun AND IiYDli0onsaxime
Group of Animals
No. of	 Zone of
Animals lysis tam2 )
(A)
Zane of
Zia 4EMM
)	 (H)
H x 100
0.2 ml protani >s sulfate
0.2 ml protamine sulfate + 1	 45
-{3.4±2.7 2.0# 6.a
8.4
a.3to.s
i2.3 ±8.7
100 g hydr000rtisone
68.4t4.7 ±8.1
0.2 ml protamine sulfate + 2 mg/	 4 42 ,5 ±3.0 2.. ± i .7 s.s ±t.o
100 g hydrocortisone
abeence of an additional release cf heparin under the influenoe of hydrocortisone
is indicated by the fact that its administration in contrast to the a Viinistration
of ACTH does not resalt ,under conditians of stress effect,in a further increase in
ria ec^tiymatic fibrinolysis even in animals that received protamine sulfate. If, as
is apparent from the data of Table 4 (groups 1 and 2) and Figure 1, the adm>inis-
trativn of ACTH uxmv aces .duruq immobilization, the absolute amount of nonenzy-
matic fibrinolytic activity 2.5-fold (from 32.9 to 80.3 mm 2), and its peroentaye
in the total fibrinolytic activity of blood 1.5-fold (from 40 to 600, then the
administration of hydr000rtisone (1 and 2 mg/100 g) does not yield an effect, and
nonenzymatic fibrinolytic activity remains the acme as in the animals exposed only
to i:mobilization (groups 3 and 4) .
Wle
eo	 80
70	 -1
60	 F1
M .	 50
11D
	
40SO.^p
10 iJ
fD	 ^'1
	
fL+
I	 P	 J	 4	 3	 6	 7	 a
Figure 1. No wun mntic Fibrinolytic Activity in Intact Rats During Immobilization
Stress After Administration of Protmmine Sulfate, AC1H and Hydrocortisone
[Key on next page]
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KY=
Light aobnow--+absolute ancient, in mm2= shaded col
	 of WW
fiber activity
1. Mysiological solution 	 S. 0.2 ml pine sulfate + 1 mg/100 g
2. ACM	 tWdr+000rtisone
3. 0.2 ml pcotami:s sulfate 	 6. Same + 2 ®g/100 9 2 tam tj sone
4. 0.2 ml protmine sulfats +ACM 7. 1 mg/100 9 hydroaartisors
S. 2 mg/100 9	 one
MMU 4.	 F	 ALTWM D[MnG DMILMA27M STASSS Arm
CB' AM AND
No. of ! Zone of 	Zone of
Group of Animals	 Animals Lysis (mm2) ly-sis t"2) B x 100
Physiological solution	 2N 78.0±6.2 3..9±4.0 40.A±4.0
AM	 Ai 136.74-4.2 A0.3 r2.3 60.0 r0.414 76.14-3.0 26.9#1.5 35.8±1.t1
Hydrocortisone 	 MV100 g	 13 83.o- 4.5
T
30.4+2.2 36.44-1.6
Hydr000rtisone 2 mg/100 g
Since hydr000 tiscne did not induce release of heparin, it should be consid-
ered that the stimulating effect of AC7H on this release is riot mediated through
activation of corticosteroicl secretion.
What then is the role of cartioosteroids? It is known that AM in the ab-
sence of glu0000rtieoids does not irncrease r= nzymatic fibrinolytic activity in
adrenalectimized rats in a stress situation, while hydr000rtisane normalises in
than the reaction of the antL=Wlative system to the stress effect, and increases
the no raymatic fibrinolysis to a level characteristic for intact animals (111.
Evidently here the permissive effect of glu0000rticoids is displayed, which
as is known, is also used in the fact that a certain annoentration of gluoo-
oorticoids in the oxganisn is necessary for implementation of a mvber of physio-
logical and bioahe deal reactions. This is indicated by the results of the exper-
iments we conducted with banding heparin by protamfne sulfate in adremlectimized
rats within 48 h after removal of the adrenal glands, when an acute deficit of
8
owtiaoseloid honaan 1 oomm in them (20).__ apoc,U-- data are pcorenbsd O
in Table 5 and Figure 2.
7NUE 5. Na+ENZTIC F 	 ACTIVITY DLPJM	 SOMSS IN .iDFMM-
IECDM ZW AND4" AFM	 OP PKMKM S= M t ACM MD
1^1^YYIOIITOfy1*'	 <
NO. 
of =(WA
	 Zane of
Group of Animals	 Awls 
	 (B) B_
Physiological solution
0.2 ml pmtmine sulfate 	 111 4^1.;±2.4 12.8 * f.7 25.,k3.4
0.2 ml p wtamine sulfate +AM	 14 33.5 t 2.0 5.6 - 1 3 16.11 + 3.n
0.2 ml Xotamine sulfate + 1 mg^	 1 + 43.9 • 2.3 4.64  1.5 141.1	 4- 3.3
100 g	 one	 h 51191 2,.i 1^.2- i.s ^':1.$±~.5
0.2 ml protamine sulfate +,ACTH
+ 1 mg/100 g hydr000lrtiwme 
so
IV
^	 w
rMJ
r	 ^	 4	 s
Figure 2. 1.4r-,rnenzymetic Fibrinolyt activity in 	 Rats During
Immobilizatim Stress AL,.x Administration of Protamine Sulfate, ACM
and
1. Physiological aolutian	 4. 0.2 ml protmmine sulfate + 1 mg/100 g
2. 0.2 ml protamine sulfate	 hydr000^rtisone
3. 0.2 ml protodne sulfate +ACM 5. 0.2 ml protaaim sulfate + ACM + 1 ml/
100 g hydr000artisone
Aaaining designations the same as in Figure 1.
As one can see from the data given in Table 5, protamine sulfate bonded heparin
in the aidm alectimized animals and vapletely blodcad nxw zymatic fibrinolysis
(group 2) . The ad drdstratian of ACM an a background of PLmtxdm sulfate (group 3) ,
9
having induced a coo-yditional release of heparin, stimaatisd no^hensymatfc fibrin-
olysis, but it did not reach tha level ahatactreristic for
	 sad animals
exposed to iimcbih
 + zatio n stress (group 1); it was 401 Lower. An even lower effect
Me yielded by the adadnistrati.an of gluccooatisone an the badogroand of ptotsmine
sulfa're (grata 4) : in this Case the -x^*w mymetic fibrinolytic activity was 2.5-fold
lower than in the adrenalectimized ani reds that did not receive protamine sulfate,
and its POrCOntage in the total fibrinolytic activity of the blood was only 10.11,
i.e., was the same as in the intact rats who received
	 000rtisathe after bonding
Of heparin by protamine sulfate (coupwo Table 3 groups 2 and 3) . We see a cam-
pletrely different picture in the
	 mid animals whc received after pirota-
mine sulfate,ACTH and hydr000rtisore (group 5): in them the nonenzymatic fibrino-
lytic activity,both according to the absolute amount and the peroentage in the
total fibrinolytic activity of the blood ,again reached that level that is character-
istic for
	 animals exposed to the stress effect without bonding of
heparin by pr+otanine sulfate.
This, we see that for focmticn of omplex heparin Co ipounds that ixplaaent
noneshzymeitic fibrinolysis, a small role is played by the pr o m m-oe of a sufficient
titer of heparin in the blood, which evideh•
_tly is guaranteed in a stress situation,
in particular by AM. A certain Wysiologicel) concentration of glue000rticoid
is also necessary, without whose permissive activity this oaaplex-fonmtien cannot
be mxx essfuilly rem Iizsd.
In " ght of the permissive effect of gluooeorti
 voids it baccumsishdehrstardable
how the pir nmiee of a high level of heparin in the blood is combined with reduced
process of emplex heparin compound formation in adrenalectimized rats in certain periods
after reroval of the adrenal glands. 4he high heparin content in blood after
10
adronalectairi is a known fact 116 0
 19, 27). Orr can justifiably hypothesize that
this him heparin aac:ts- I to a gain measure is fined by the ACM secretion
i-"O"int.ofter rozoal of the adrenal glands (22, 25, 26) . Nonrssymeitic fibrinolysis
in the adronLlectaaixed animals is retarded beos:uee for its
	 "we
bin seen, the preeenoe of g lu0000rtiocids is nooeswary.
In conclusion one should state that the literature on the effect of ACZH on
heparin content in the blood is fairly contradictory. One can na a naober of
ea imentatl and clinical works that speak of an increase in the hepeurin titer with
administration, especially multiple, of ACTH 11, 17, 18, 23) . On the other hand,
there are known works that indicate the decrease in heparin content under- the influ-
ence of AM% [2). It is possible that the reason for these disagreement is hidden
to a certain measure in the fact that AM, stimulating the release of heparin, also
intensifies the formation of its ocxplex owpocado, and oonsec m*-1y, in each case, /740
it is evidently necessary to take into consideration the inverse relationship
between the heparin level in the blood and the intercity of formation of its complex
cotWounds.
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